Michael Korn, MD on Targetable Molecular Pathways in KRAS Wild-Type

Michael Korn, MD on Targetable Molecular Pathways in KRAS Wild-Type

User Photo
Cancer-News

3 months
40 Views
Share
Want to watch this again later?
Sign in to add this video to a playlist. Login
0 0
Category:
Description:

Michael Korn, MD, CMO of Caris Life Sciences discusses the enrichment of alterations in targetable molecular pathways in KRAS wild-type pancreatic cancer.

Read here: https://meetinglibrary.asco.org/record/186629/abstract

Up Next Autoplay
>